Christopher Ching

Assistant Professor Of Research Neurology

Image of Christopher Ching
Is this your profile? Click to edit

Overview

Dr. Ching is an Assistant Professor at The Imaging Genetics Center, part of the Mark and Mary Stevens Neuroimaging and Informatics Institute, where his research focuses on neuroimaging and genomic markers of psychiatric and neurodegenerative disorders. As a core organizing member of the Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium (ENIGMA), he designs and implements standardized processing and analysis techniques for large-scale, international neuroimaging studies for a wide range of brain conditions. He leads the ENIGMA Bipolar Disorder Working Group, an effort including >200 researchers from around the world pooling data and resources to improve our understanding of the biological processes driving bipolar disorder. In complementary work, he studies rare copy number variants like 22q11.2 Deletion Syndrome to understand how certain rare genetic mutations can lead to increased risk for developing psychiatric illness. Finally, he leads several large-scale transdiagnostic neuroimaging and genomic initiatives mapping the common and distinct brain and clinical factors across a range of serious mental illnesses.

Awards

  • USC: Postdoctoral Fellowship in Biomarkers in Alzheimer’s Disease NIAT32AG058507, 2019
     – 2021
  • UCLA: Neurobehavioral Genetics Predoctoral Fellowship, NIH/NIMH 5T32MH073526, 2015
     – 2016
  • UCLA: Neuroimaging Training Program, National Institutes of Health, R90 DA022768 and T90 DA023422, 2012
     – 2013
  • UCLA: National Science Foundation Alliance for Graduate Education and the Professoriate Grant, 2012
     – 2012

Education and Training

  • UCLA — PhD — Neuroscience
  • Pomona College — BA — Neuroscience/Philosophy

Research Keywords

  • Neuroscience
  • Neuoroimaging
  • Psychiatric Disorders
  • Genetics
  • Neurodegenerative Disease

Publications

  • Distribution and age-interactions of cortical thickness associated with specific classes of medication used to treat obsessive-compulsive disorder: Results from the international ENIGMA consortium. Cortex. 2026 Sep 02; 205:1-23.. View in PubMed
  • Brain Morphology Mediators of the Association of Childhood Trauma With Bipolar Disorder: An International ENIGMA Bipolar Disorder Working Group Study. JAMA Psychiatry. 2026 Aug 01; 83(8):847-856.. View in PubMed
  • Depression and hippocampal subfield volume in older adults. Transl Psychiatry. 2026 Jul 14.. View in PubMed
  • Brain Ageing in Social Anxiety Disorder: An ENIGMA-Anxiety Mega-Analysis Across 26 International Cohorts. medRxiv. 2026 Jul 06.. View in PubMed
  • A 3D Brain Geometry Toolkit for Multisite Neuroimaging Analysis. bioRxiv. 2026 Jul 02.. View in PubMed
  • Shared and specific associations of amygdala nuclei volumes with PTSD symptom domains and childhood trauma: An ENIGMA-PGC PTSD mega-analysis. Mol Psychiatry. 2026 Jul 02.. View in PubMed
  • White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysis. Mol Psychiatry. 2026 Sep; 31(9):5423-5430.. View in PubMed
  • The Hidden Architecture of Brain Structural Variability in 22q11.2 Deletion Syndrome: A Multi-site Study. medRxiv. 2026 May 21.. View in PubMed
  • Structural Brain Network Alterations in Relation to Treatment and Illness Severity in Bipolar Disorder. Biol Psychiatry. 2026 May 04.. View in PubMed
  • Structural Brain Network Alterations in Relation to Treatment and Illness Severity in Bipolar Disorder. bioRxiv. 2026 Mar 31.. View in PubMed